Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Report ID | 136460 |
Drug Identification Number | 02439409 |
Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
Common or Proper name | Ropivacaine Hydrochloride Injection, USP 10 mg/mL Ampoule 20 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | EPIDURAL EPIDURAL |
Packaging size | 20 mL |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-03-26 |
Actual start date | 2021-03-26 |
Estimated end date | 2021-04-30 |
Actual end date | 2021-04-15 |
Shortage status | Resolved |
Updated date | 2021-04-16 |
Company comments | Fresenius Kabi Canada Ltd. is pleased to advise that the backorder on Ropivacaine Hydrochloride Injection, USP has been resolved earlier than anticipated and the product is now available across all distribution centers. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-04-16 | English | Compare |
v5 | 2021-04-15 | French | Compare |
v4 | 2021-04-15 | English | Compare |
v3 | 2021-03-27 | English | Compare |
v2 | 2021-03-26 | French | Compare |
v1 | 2021-03-26 | English | Compare |
Showing 1 to 6 of 6